Delivery Order SPE2DB22D3301-SPE2DB24FZ2AQ

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,708.59 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty medication used in the treatment of iron deficiency anemia. The award has an ultimate completion date of March 4, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $3,385.70 contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a period of performance through April 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FVQ33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,659.14 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a period of performance through May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FERAHEME 510 MG/17 ML VIAL 17ML. The contract has a ceiling value of $3,856.10 and a performance period ending on June 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,037.34 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has a completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, and has a ceiling value of $4,437.36. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is June 12, 2024. This award is not associated with a set-aside program. AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical supply product, with a firm fixed price of $13,541.33 and a completion date of May 19, 2025. This is a delivery order contract, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,900.25 firm fixed price delivery order is for FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a completion date of February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a ceiling value of $8,345.80 and a firm fixed price. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, with a ceiling value of $3,161.81 and a period of performance through April 11, 2025. The contract is not set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2AQ
    Delivery Order

This $8,655.67 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FERAHEME 510 MG/17 ML VIAL 17ML pharmaceutical products. The order has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a range of medical commodities and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for pharmaceutical products. This contract award is not designated as a set-aside.

Generated 10/31/24, 9:42 AM